May 05, 2020 / 08:30PM GMT
Operator
Good afternoon, and welcome to the Synthetic Biologics 2020 First Quarter Investor Conference Call.
At this time, I would like to turn the call over to Vincent Perrone, Director, Corporate Communications, at Synthetic Biologics. Please go ahead, Vincent.
Vincent I. Perrone - Synthetic Biologics, Inc. - Director of Corporate Communication
Thank you, Tayla, and good afternoon, everyone. Welcome to Synthetic Biologics' 2020 First Quarter Investor Conference Call. Today, I'm joined remotely by our Chief Executive and Financial Officer, Steven Shallcross; Dr. Michael Kaleko, Senior Vice President of Research and Development; and Dr. Vince Wacher, Head of Product and Corporate Development.
Synthetic Biologics issued a press release this afternoon which provided operational highlights and reported our financial results for the quarter ending March 31, 2020. The release can be found on the Investor Relations section of our website.
During our call today we'll provide an operational update on our GI- and microbiome-focused clinical programs
Q1 2020 Synthetic Biologics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot